These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7880725)

  • 41. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
    Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
    Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutation and expression of the DCC gene in human lung cancer.
    Kohno T; Sato T; Takakura S; Takei K; Inoue K; Nishioka M; Yokota J
    Neoplasia; 2000; 2(4):300-5. PubMed ID: 11005564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
    Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Growth inhibitory effects of lipofectamine-mediated DCC gene on ovarian epithelial carcinoma].
    Li PL; Hu CJ; Li CM; Meng CY; Gao L
    Zhonghua Fu Chan Ke Za Zhi; 2006 Mar; 41(3):186-9. PubMed ID: 16640886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bcl-2 expression and allelic loss of the p53 gene in gastric carcinomas.
    Saegusa M; Takano Y; Kamata Y; Okayasu J
    J Cancer Res Clin Oncol; 1996; 122(7):427-32. PubMed ID: 8690754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Loss of heterozygosity involving DCC gene in human colorectal cancers is correlated with the metastatic potential].
    Gao S; Xu W; Wan Y
    Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):250-2. PubMed ID: 9387312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered phenotype of HT29 colonic adenocarcinoma cells following expression of the DCC gene.
    Velcich A; Corner G; Palumbo L; Augenlicht L
    Oncogene; 1999 Apr; 18(16):2599-606. PubMed ID: 10353603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequent inactivation of RUNX3 in endometrial carcinoma.
    Yoshizaki T; Enomoto T; Fujita M; Ueda Y; Miyatake T; Fujiwara K; Miyake T; Kimura T; Yoshino K; Kimura T
    Gynecol Oncol; 2008 Sep; 110(3):439-44. PubMed ID: 18572225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The DCC protein and prognosis in colorectal cancer.
    Shibata D; Reale MA; Lavin P; Silverman M; Fearon ER; Steele G; Jessup JM; Loda M; Summerhayes IC
    N Engl J Med; 1996 Dec; 335(23):1727-32. PubMed ID: 8929264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Abnormalities of the RB1 and DCC tumor suppressor genes: uncommon in human pancreatic adenocarcinoma.
    Barton CM; McKie AB; Hogg A; Bia B; Elia G; Phillips SM; Ding SF; Lemoine NR
    Mol Carcinog; 1995 Jun; 13(2):61-9. PubMed ID: 7605581
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of heterozygosity detected in formalin-fixed, paraffin-embedded tissue of colorectal carcinoma using a microsatellite located within the deleted in colorectal carcinoma gene.
    Huang TH; Quesenberry JT; Martin MB; Loy TS; Diaz-Arias AA
    Diagn Mol Pathol; 1993 Jun; 2(2):90-3. PubMed ID: 8269282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alterations of the tumour suppressor gene DCC in neuroblastoma.
    Kong XT; Choi SH; Inoue A; Takita J; Yokota J; Hanada R; Yamamoto K; Bessho F; Yanagisawa M; Hayashi Y
    Eur J Cancer; 1997 Oct; 33(12):1962-5. PubMed ID: 9516833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of heterozygosity and loss of expression of the DCC gene in gastric cancer.
    Fang DC; Jass JR; Wang DX
    J Clin Pathol; 1998 Aug; 51(8):593-6. PubMed ID: 9828817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of the deleted in colorectal cancer gene is related to prognosis in DNA diploid and low proliferative colorectal adenocarcinoma.
    Sun XF; Rütten S; Zhang H; Nordenskjöld B
    J Clin Oncol; 1999 Jun; 17(6):1745-50. PubMed ID: 10561211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infrequent inactivation of DCC gene in replication error-positive colorectal cancers.
    Yamamoto H; Itoh F; Kusano M; Yoshida Y; Hinoda Y; Imai K
    Biochem Biophys Res Commun; 1998 Mar; 244(1):204-9. PubMed ID: 9514909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus.
    Chenevix-Trench G; Leary J; Kerr J; Michel J; Kefford R; Hurst T; Parsons PG; Friedlander M; Khoo SK
    Oncogene; 1992 Jun; 7(6):1059-65. PubMed ID: 1594239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of the tumor suppressor gene DCC in human gliomas.
    Scheck AC; Coons SW
    Cancer Res; 1993 Dec; 53(23):5605-9. PubMed ID: 8242611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro analysis of the role of DCC in mucus-secreting intestinal differentiation.
    Fabre M; Martin M; Ulloa F; Real FX
    Int J Cancer; 1999 May; 81(5):799-807. PubMed ID: 10328236
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer.
    Semczuk A; Marzec B; Roessner A; Jakowicki JA; Wojcierowski J; Schneider-Stock R
    Virchows Arch; 2002 Dec; 441(6):577-83. PubMed ID: 12461615
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of heterozygosity at the DCC gene locus is not crucial for the acquisition of metastatic potential in oesophageal squamous cell carcinoma.
    Maesawa C; Tamura G; Ogasawara S; Suzuki Y; Sakata K; Sugimura J; Nishizuka S; Sato N; Ishida K; Saito K; Satodate R
    Eur J Cancer; 1996 May; 32A(5):896-8. PubMed ID: 9081374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.